Project Grant R01HD114264
Award Date 9/20/24
Completion Date 6/30/27
Dollars Obligated $1.6M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Portland, OR 97239, USA
Similar Awards
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $244,328 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to study the impact of in utero HIV and antiretroviral exposure on the placenta and birth weight. The key objectives are to simultaneously measure antiretroviral (ARV) levels in pregnant women and their children's hair to quantify drug exposure to...
- This federal Project Grant award of $1,332,155 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports a research initiative at Emory University to optimize immunotherapy strategies for achieving virologic control in HIV-infected infant macaques. The primary objectives are to evaluate the impact of activating the non-canonical NF-kB pathway, stimulating TLR7/8, and using the attachment inhibitor...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) provides $251,250.00 to the University of Massachusetts Medical School (UMass Medical) to support the planning and development of a proof-of-concept Phase I clinical trial. The trial will evaluate the safety, tolerability, and ability of a single administration of two AAV9-vectored broadly-neutralizing antibodies to enable sustained HIV-1 control in...
- This $232,500 Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) to The Johns Hopkins University supports research into the virologic determinants leading to long-term antiretroviral therapy-free control in infants with in utero HIV-1 infection. The study aims to create infectious molecular clones from proviral HIV-1 DNA in participants from the IMPAACT P1115...
- The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) awarded a $844,250 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to the University of Nebraska Medical Center (UNMC) on July 1, 2025. The grant funds a 2-year research project to develop a non-invasive magnetic resonance imaging (MRI) biomarker that can detect adverse neurodevelopmental effects in fetuses exposed to antiretroviral (ARV) drugs during...
- This $812,810 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research at Emory University to generate highly differentiated natural killer (NK) cells and evaluate their synergistic effects with broadly neutralizing antibodies in reducing the SIV reservoir and establishing viral control in the absence of antiretroviral therapy (ART). The key objectives are to: 1) define...
- This Project Grant award of $1,144,344 from the National Institute on Drug Abuse (NIDA)'s Drug Use and Addiction Research Programs (CFDA 93.279) supports research aimed at eliminating the central nervous system reservoir of simian immunodeficiency virus (SIV) in methamphetamine-exposed rhesus macaques receiving antiretroviral therapy. The Texas Biomedical Research Institute, doing business as the Southwest Foundation for Biomedical Research, will leverage novel AAV serotype gene therapy to...
- This federal Project Grant award of $499,140.00 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) will fund the "TSEPAMO NEXT GENERATION: OPTIMIZING HIV TREATMENT AND PREVENTION STRATEGIES FOR PREGNANT WOMEN IN BOTSWANA" research project at the Harvard T.H. Chan School of Public Health. The key objectives of this 5-year project are to: 1) investigate the safety and efficacy...
- This Cooperative Agreement award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will provide $6,358,233 from September 2025 to August 2030 to President and Fellows of Harvard College to conduct the "Pediatric HIV/AIDS Cohort Study (PHACS): Research on Immune Aging, Sexual and Reproductive Health, and Perinatal Acquisition: Elucidating Relationships in...
- This federal Project Grant award, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to investigate the impact of a glucagon-like peptide-1 receptor agonist on pathogenesis and antiretroviral therapy (ART) administration in people living with HIV (PWH). The $780,853 award, with a period of performance from April 10, 2025 to March 31, 2030, will support research...